Filing Details
- Accession Number:
- 0001209191-19-040581
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-02 20:11:39
- Reporting Period:
- 2019-06-28
- Accepted Time:
- 2019-07-02 20:11:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775259 | Elias Kouchakji | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Svp, Clinical Dev, Drug Safety | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-06-28 | 2,873 | $45.00 | 109,199 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
Billionaire Hedge Funds
